Monday, Aug 26, 2019
HomeNewsFourth Terrace Diagnostic Center partners with Nuevozen to develop AI-powered breast cancer solution

Fourth Terrace Diagnostic Center partners with Nuevozen to develop AI-powered breast cancer solution

Nuevozen Corporation, a leading provider of innovative cancer detection solutions, is pleased to announce their partnership with Fourth Terrace Diagnostic Centre (FTDC) in the development and installation of their artificial intelligence (AI)-powered breast cancer solution at Fourth Terrace, a leading diagnostic center in The Bahamas.

This AI-based solution is being developed to assist radiologists in the diagnosis and identification of women’s individual risk of developing breast cancer. The Bahamas ranks among the top 20 countries in the world in terms of the number of women per capita with breast cancer.

The breast cancer incidence rate for women in The Bahamas is increasing, and 48 percent of Bahamian patients diagnosed with breast cancer are less than 50 years of age and are diagnosed at stage III.

Three different genes influencing breast cancer have been identified in Bahamian women, making it a country with one of the highest proportions of mutations in the world, and approximately 24 percent of the women with breast cancer in The Bahamas have one of these mutations. There are also many other risk factors that are still not well understood.

Fourth Terrace Diagnostic Centre’s founder, CEO and Lead Radiologist Dr. C. Elizabeth Darville MBBS, FRCP, has been at the forefront of cancer care in The Bahamas for more than 35 years. She has promoted screening from earlier ages for Bahamian women and has seen the benefit of early diagnosis for her patients.

“If Nuevozen’s AI solution can assist our radiologists in improving breast cancer diagnosis, we can improve patient outcome through early detection,” said Dr. Darville.

“Also if an AI solution is able to predict individual Bahamian women’s risk of developing breast cancer, we will be able to move from age-based screening to risk-based screening, and this will dramatically improve early detection and survival.

“We are pleased to announce that Dr. Vijay Anand Subramanian, who has been a part of our team for many years, has been appointed as the director of our Artificial Intelligence Research and Development Department.”

Fourth Terrace Diagnostic Centre President Stanley Darville explained, “Technological advances in medicine continue to occur at almost an exponential pace and Fourth Terrace Diagnostic Centre is working closely with our local Bahamian IT firm Redstone Technologies to provide the high level of support for our data center and the immense computing power that is needed to implement Nuevozen’s Artificial Intelligence solution.”

Co-founder and CEO of Nuevozen Karan Aujla said, “We are extremely excited to be working with FTDC.

“Current risk models are population-based and focus on lifetime or long-term risk. Many of the age-based risk models don’t apply to Bahamian women due to the high incidence of genetic mutations, and available data has shown that by using the genetic information together with, and the information available in the DICOM images and the patient history, we can come up with a more accurate risk assessment.

“I believe that by analyzing patient data using AI techniques we can help healthcare providers in improving prevention and treatment of breast cancer.”

Latest posts by The Nassau Guardian (see all)

FOLLOW US ON:
Constitution must no
Shantytown case adjo